Nanotechnology holds promise for STD drug delivery

		IMAGE: This is Kim Woodrow from Yale University. Click here for more information.

New Haven, Conn. — Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs — small interfering RNA (siRNA) molecules that silence genes — the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.